Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Epidemic Preparedness: COVID-19

Date added: 23 Apr 2020

This call aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and to increase research and response capacity.

Amount
Up to £2M
Agency or Funder
Wellcome Trust & UK Department for International Development (DFID)
Eligibility (if available)

PhD plus significant postdoctoral experience in an academic research organisation, a not-for-profit or government body, a private sector organisation

Foreign participation? (where known)
Yes

Flagship Covid-19 and cardiovascular health projects

Date added: 08 May 2020

UK researchers are invited to study cardiovascular complications in COVID-19 infection, their prevention, short and long-term impact, and why patients with heart and circulatory diseases are at greater risk of adverse outcomes.

Amount
N/A
Agency or Funder
The British Heart Foundation
Eligibility (if available)

UK cardiovascular research community

Foreign participation? (where known)
No

AHA Rapid Response Grant
COVID-19 and Its Cardiovascular Impact

Date added: 23 Apr 2020

Cardiovascular-focused applications that will contribute to understanding the cardiovascular and cerebrovascular pathogenesis, diagnosis, prevention, clinical manifestations, clinical management (including critical care management) and social beha

Amount
up to $100,000 (U.S. dollars)
Agency or Funder
American Heart Association
Eligibility (if available)

Not specified

Foreign participation? (where known)
Yes
Date application deadline

Improving patient health and understanding the pathogenesis of COVID-19 to contain the spread

Date added: 08 May 2020

€7M are available for collaborative research projects lasting 12 months that can rapidly acquire knowledge about potential clinical and public health measures to be used immediately to improve patient health.

Amount
Up to €1M per project, €7M total
Agency or Funder
Ministero della Salute
Eligibility (if available)

Leading institutional applicant must be a designated Italian clinically oriented biomedical institute (IRCCS); collaborations must include a minimum of five and a maximum of seven partners

Foreign participation? (where known)
No
Date application deadline

Postdoctoral Fellowship in COVID-19 Pathogenesis

Date added: 06 May 2020

One postdoctoral position is available at the Laboratory of Innate Immunity and Microbial Pathogenesis, São Paulo, Brazil, for research into the role of inflammatory cytokines in COVID-19.

Amount
Up to 7.373 BRL
Agency or Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Eligibility (if available)

PhD holders, preferably specialised in celular and molecular biology, biochemistry and epidemiology

Foreign participation? (where known)
Yes
Date application deadline

Swiss national COVID-19 research programme

Date added: 08 May 2020

Projects must advance the understanding of COVID-19 and the development of vaccines, therapeutics, and diagnostics. Multidisciplinary collaborations and use of international research networks are encouraged.

Amount
CHF 20M
Agency or Funder
Swiss National Science Foundation
Eligibility (if available)

Independent researchers holding a PhD or equivalent

Foreign participation? (where known)
Yes
Date application deadline

Understanding the pathobiology and clinical implications of SARS-CoV-2

Date added: 29 Apr 2020

Proposals may address the biology of respiratory viruses, epidemiological approaches to them, development of novel therapeutics and vaccines, deciding host factors and individual, regional, or social factors affecting community spread of COVID-19.

Amount
$100.000 (U.S. dollars) per year, for up to two years
Agency or Funder
American Lung Association
Eligibility (if available)

Applicants must hold a PhD and work in a non-profit academic institution

Date application deadline

COVID-19 in vulnerable populations, its long-term effect, and the effectiveness of remdesivir

Date added: 06 Jul 2020

Projects lasting up to 9 months should collect data on the clinical course and outcome of COVID-19 in vulnerable populations, investigate long-term consequences of COVID-19 in patients, or test the safety and effectiveness of remdesivir in treatin

Amount
Up to $250,000 USD
Agency or Funder
GILEAD
Foreign participation? (where known)
Yes
Date application deadline

Improving outcomes in people with cystic fibrosis

Date added: 06 Jul 2020

The research should determine how susceptible cystic fibrosis (CF) cells are to COVID-19, identify and evaluate responses to the virus in people with CF, and understand how commonly prescribed medications used in CF may alter responses to the viru

Amount
Up to $125,000 USD per year
Agency or Funder
Cystic Fibrosis Foundation
Eligibility (if available)

Applicants must be independent investigators

Foreign participation? (where known)
Yes
Date application deadline

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID & NIGMS
Eligibility (if available)

Existing grantholders wishing to expand the scope of their research.

Foreign participation? (where known)
Yes
Date application deadline

Emergency competitive revisions for research on SARS-CoV-2 and COVID-19

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Existing NIAID grantholders

Date application deadline

Existing calls welcome proposals to develop medical countermeasures against SARS-CoV-2/COVID-19

Date added: 23 Apr 2020

NIAID announces that a number of existing calls will particularly welcome research objectives related to pathogenicity, transmission, medical countermeasures, pre-clinical testing of vaccines and therapeutics.

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Date application deadline